Skip to main content
. 2009 Nov 18;115(5):1026–1036. doi: 10.1182/blood-2009-06-227579

Table 3.

Differentially expressed genes in the molecularly defined ATLL

Genes in classifier Other differentially expressed genes
TCR signaling components and costimulatory/inhibitory molecules TCRα, TCRβ, CD1ϵ, CTLA4, CD99, TRAC ICOS, CD28, CD1B, CD1C, CD6, LAT, FYN, FYB
T-cell activation or differentiation TNFRSF25(DR3), CD27, LEF1, NFATC1 IL2RA (CD25), IL4R, IL18R1, IL23R,IL12RB2, MAL, IL4R, GATA3
Proinflammatory CCR4, CCL13, IL23R IL6, IL6ST, CCL26
Melanoma-associated MAGEA4, MAGEA9, MAGEA4B MAGEB1, MAGEA3
Immune modulatory enzymes PGDS (hematopoietic) PTGER4, PTGER3
B cells AICDA, MTA3
Previously published genes associated with ATLL IKZF2, RGS13, PTHLH, RGS13, CADM1(TSLC1) TCF4
HTLV-1 Tax target c-Myc, TIAM1, PDE8B, DOK5, ARNT2, UST, PGDSMYCN, PDE8B, CEBPA, RGS13, PTHLH, SMARCA2, CD99, CADM1(TSLC1),CCR4, RGS2, SPINK2, RORA IL2RA, CFLAR
Treg cell chemoattractant CCL22, CCL20, CCL17
Cytotoxic molecules TIA1

For abbreviations, see Table 2.

*

Only up-regulated representative genes are included in each signature.